KEYTRUDA QLEX: payments to doctors
Payments that named KEYTRUDA QLEX as the associated drug or biological, reported under the Sunshine Act for program years 2019–2025.
- Total reported
- $202K
- Providers
- 5,946
- Transactions
- 8,150
- Average per transaction
- $25
The per-transaction average — $25 — is the number that tells you what kind of spending this is. A few dollars means meals at product presentations, reported by the thousand. Hundreds or thousands means consulting, speaking or royalty arrangements with a much smaller group of physicians. Across all 5,946 providers the average total is $34, but that average hides a very steep distribution.
Companies reporting these payments
| Company | Total reported | Share |
|---|---|---|
| Merck | $201,867 | 100.0% |